Should imporvement in rheumatoid arthritis clinical trials be defined as fifty percent or seventy percent improvement in core set measures, rather than twenty percent?
Open Access
- 1 September 1998
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 41 (9), 1564-1570
- https://doi.org/10.1002/1529-0131(199809)41:9<1564::aid-art6>3.0.co;2-m
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion ProteinNew England Journal of Medicine, 1997
- Treatment of early Rheumatoid Arthritis with minocycline or placebo. Results of a Randomized, double‐blind, placebo‐controlled trialArthritis & Rheumatism, 1997
- Meaningful improvement criteria sets in a rheumatoid arthritis clinical trialArthritis & Rheumatism, 1997
- American college of rheumatology preliminary definition of improvement in rheumatoid arthritisArthritis & Rheumatism, 1995
- The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trialsArthritis & Rheumatism, 1993
- Analysis of improvement in individual rheumatoid arthritis patients treated with disease‐modifying antirheumatic drugs, based on the findings in patients treated with placeboArthritis & Rheumatism, 1990
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- Comparison of low‐dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A Controlled Clinical TrialArthritis & Rheumatism, 1985
- Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritisArthritis & Rheumatism, 1983
- Low‐Dose D‐Penicillamine Therapy in Rheumatoid ArthritisArthritis & Rheumatism, 1983